Back to MRVI overview

MRVI Maravai Lifesciences Holdings PE ratio, current and historical analysis

The current PE ratio of MRVI cannot be calculated, as the latest EPS of -$0.99 is negative. The last PE ratio of Maravai Lifesciences Holdings, recorded in September 2023, was 55.56.

MRVI PE ratio history

How has MRVI's PE ratio performed in the past

The PE ratio of Maravai Lifesciences Holdings has averaged 15.98 over the last four years. Looking back at the last four years, MRVI's PE ratio peaked in the Sep 2023 quarter at 55.56, when the price was $10 and the EPS was $0.18. The lowest point was in the Dec 2020 quarter, when it reached 3.78 with a price of $28.05 and an EPS of $7.43.

Average
15.98
Median
13.06
Minimum
3.78
Maximum
55.56

Maravai Lifesciences Holdings PE ratio by year

Maximum annual increase: 597.09% in 2021

Maximum annual decrease: -67.48% in 2022

Year PE ratio Change
2023 N/A N/A
2022 8.57 -67.48%
2021 26.35 597.09%
2020 3.78 N/A
2019 N/A N/A
2018 N/A N/A

MRVI average PE ratio chart

What is the average PE ratio of MRVI for the past years
3-year avg
18.33
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A

MRVI PE vs peers

What is MRVI's PE ratio compared to its peers
Stock name PE ratio Market cap
NVAX Novavax Inc N/A $1.98B
NVCR NovoCure Ltd N/A $2.1B
MRVI Maravai Lifesciences Holdings Inc N/A $1.7B

Frequently asked questions

What is Maravai Lifesciences Holdings's PE ratio?

The current price to earnings ratio of MRVI cannot be determined, as its EPS of -$0.99 is negative.

What is the 3-year average PE ratio for Maravai Lifesciences Holdings (MRVI)?

The average PE ratio for MRVI stock over the past 3 years is 18.33.

What is the highest PE ratio for MRVI?

Over the last four years, the quarterly PE ratio reached its highest level at 55.56 in the Sep 2023 quarter.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.